E
180 Life Sciences Corp. ATNF
$1.07 -$0.01-0.93%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -66.01% -56.02% -50.05% -30.86% 10.51%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -63.94% -50.89% -43.40% -24.70% 5.65%
Operating Income 63.94% 50.89% 43.40% 24.70% -5.65%
Income Before Tax 92.85% 71.68% 59.58% 43.82% -174.14%
Income Tax Expenses 99.87% -149.22% -149.22% -149.22% -49,713.64%
Earnings from Continuing Operations 92.28% 75.71% 63.95% 48.52% -153.64%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 92.28% 75.71% 63.95% 48.52% -153.64%
EBIT 63.94% 50.89% 43.40% 24.70% -5.65%
EBITDA 64.17% 51.19% 43.65% 24.83% -5.49%
EPS Basic 98.19% 93.47% 89.21% 81.36% -68.62%
Normalized Basic EPS 94.13% 87.71% 54.30% -223.64% -335.76%
EPS Diluted 98.18% 93.47% 89.21% 81.36% -68.29%
Normalized Diluted EPS 94.13% 87.71% 54.30% -223.54% -335.79%
Average Basic Shares Outstanding 213.46% 275.01% 285.22% 278.57% 171.22%
Average Diluted Shares Outstanding 213.46% 275.01% 285.22% 278.48% 171.15%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings